VANI (Vivani Medical) Insider Ownership : 13.15 % (As of Apr. 12, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Vivani Medical Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vivani Medical's insider ownership is 13.15%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vivani Medical's Institutional Ownership is 8.40%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vivani Medical's Float Percentage Of Total Shares Outstanding is 70.16%.

Vivani Medical Insider Ownership Historical Data

The historical data trend for Vivani Medical's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivani Medical Insider Ownership Chart

Vivani Medical Historical Data

The historical data trend for Vivani Medical can be seen below:

	2024-06-30	2024-07-31	2024-08-31	2024-09-30	2024-10-31	2024-11-30	2024-12-31	2025-01-31	2025-02-28	2025-03-31
Insider Ownership	8.68	8.70	8.66	8.66	8.66	14.78	14.78	14.78	14.78	13.15

Vivani Medical Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Vivani Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivani Medical Inc (NAS:VANI) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

U5P:Germany

Address

1350 S. Loop Road, Alameda, CA, USA, 94502

Website

https://www.vivani.com

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.

Executives

Donald Dwyer	officer: Chief Business Officer	54 CHERRY FARM LANE, WEST CHESTER PA 19382
Gregg Williams	director, 10 percent owner	PO BOX 200, WALLED LAKE MI 48390-0200
Brigid Makes	officer: CFO	20245 SW 95TH AVENUE, TUALATIN OR 97062
Aaron Mendelsohn	director	224 15TH STREET, SANTA MONICA CA 90402
Joachim Eberhard Bolck	10 percent owner	33 CLUB VIEW LANE, ROLLING HILLS ESTATES CA 90274
Lisa Ellen Porter	officer: Chief Medical Officer	778 CORDILLERAS AVE, SAN CARLOS CA 94070
Truc Le	officer: COO	1905 WEST RED FOX ROAD, SANTA ANA CA 92704
Adam Mendelsohn	director, officer: CEO	C/O 5858 HORTON ST. SUITE 280, EMERYVILLE CA 94608
Wilford Dean Baker	director	200 FLYNN ROAD, CAMARILLO CA 93012-8790
Larson Alexandra L.p.	director	3797 BURNING TREE DRIVE, BLOOMFIELD HILLS MI 48302
Scott Dunbar	officer: Acting CEO	13170 TELFAIR AVENUE, SYLMAR CA 91342
Edward Jonathon Sedo	officer: Controller	4485 FORESTGLEN CT, MOORPARK CA 93021
Jessy Dana Dorn	officer: VP-Clin & Scientific Affairs	12744 SAN FERNANDO RD. SUITE 400, SYLMAR CA 91342
Matthew J Pfeffer	director
Patrick Ryan	officer: Chief Operating Officer	C/O SECOND SIGHT MEDICAL PRODUCTS, INC., 12744 SAN FERNANDO ROAD, SUITE 400, SYLMAR CA 91342